Table 4.
Coronary artery abnormalities for patients with Kawasaki disease in 4 groups during 12 months follow-up.
| Cardiac complications | Acute phase | 1 month | 3 months | 6 months | 12 months | ||
|---|---|---|---|---|---|---|---|
| Group 1 (n = 77) | CALs | 11 (14.3) | 9 (11.7) | 6 (7.8) | 2 (2.6) | 1 (1.3) | |
| CAAs | 2 (2.6) | 2 (2.6) | 1 (1.3) | 1 (1.3) | — | ||
| GCAAs | 1 (1.3) | 1 (1.3) | 1 (1.3) | — | — | ||
| Group 2 (n = 817) | CALs | 159 (19.5) | 90 (11.0) | 31 (3.8) | 10 (1.2) | 7 (0.9) | |
| CAAs | 29 (3.5) | 14 (1.7) | 6 (0.7) | 5 (0.6) | 2 (0.2) | ||
| GCAAs | 3 (0.4) | 2 (0.2) | 2 (0.2) | 1 (0.1) | — | ||
| Group 3 (n = 249) | CALs | 88 (35.3) | 51 (20.5) | 23 (9.2) | 15 (6.0) | 11 (4.4) | |
| CAAs | 22 (8.8) | 16 (6.4) | 13 (5.2) | 10 (4.0) | 8 (3.2) | ||
| GCAAs | 2 (0.8) | 2 (0.8) | 3 (1.2) | 3 (1.2) | 3 (1.2) | ||
| Group 4 (n = 138) | CALs | 81 (58.7) | 56 (40.6) | 38 (27.5) | 29 (21.0) | 20 (14.5) | |
| CAAs | 42 (30.4) | 30 (21.7) | 21 (15.2) | 20 (14.5) | 13 (9.4) | ||
| GCAAs | 6 (4.3) | 8 (5.8) | 8 (5.8) | 5 (3.6) | 5 (3.6) | ||
| p value | CALs | Group 1 vs. 2 | 0.269 | 0.857 | 0.087 | 0.277 | 0.515 |
| Group 2 vs. 3 | <0.001 | <0.001 | 0.001 | <0.001 | 0.001 | ||
| OR 2.3 95% CI 1.7-3.1 |
OR 2.1 95% CI 1.4-3.0 |
OR 2.6 95% CI 1.5-4.5 |
OR 5.2 95% CI 2.3-11.7 |
OR 5.3 95% CI 2.0-13.9 |
|||
| CAAs | Group 1 vs. 2 | 0.491 | 0.407 | 0.469 | 0.418 | — | |
| Group 2 vs. 3 | 0.001 | <0.001 | <0.001 | <0.001 | <0.001 | ||
| OR 2.7 95% CI 1.5-4.7 |
OR 3.9 95% CI 1.9-8.2 |
OR 7.4 95% CI 2.8-19.8 |
OR 6.8 95% CI 2.3-20.1 |
OR 13.5 95% CI 2.9-14.1 |
|||
Expressed as n (%). CALs: coronary artery lesions; CAAs: coronary artery aneurysms; GCAAs: giant coronary artery aneurysms. OR: odds ratio.